What's breaking now, across thousands of outlets.
As psychedelic drugs inch closer to commercialization, two House lawmakers are charting a path forward for their inevitable rollout and what any potential accompanying legislation could focus on. The chairs of the Congressional Psychedelics Advancing ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
When it's time for another vaccine, many people may ask themselves a familiar question: Do I really need another one? The answer may depend, at least in part, on how protected they think they already…
Health insurers in privatized Medicare Advantage are for the most part maintaining their 2027 geographic footprints after a multi-year period of retrenchment.
Here are some practical, realistic steps to overcome phone addiction and stop endless scrolling, starting with simple digital boundary changes and real-world habits.
New York City drug developer Kallyope is rebranding as TriGemX Bio as it focuses solely on treating migraine. To support the restructured company and its Phase 3 trials of a former Tanabe Pharma drug…
